Haj-Yehia, E., Mincu, R. I., Schulte, P., Korste, S., Dautzenberg, S., Michel, L., . . . Totzeck, M. Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapy. Elsevier.
Chicago Style (17th ed.) CitationHaj-Yehia, Elias, Raluca I. Mincu, Phillip Schulte, Sebastian Korste, Samuel Dautzenberg, Lars Michel, Amir A. Mahabadi, Tienush Rassaf, and Matthias Totzeck. Hemoglobin Is Associated with Cardiotoxicity in Melanoma Patients Without Anemia Receiving Immune Checkpoint Inhibitor Therapy. Elsevier.
MLA (9th ed.) CitationHaj-Yehia, Elias, et al. Hemoglobin Is Associated with Cardiotoxicity in Melanoma Patients Without Anemia Receiving Immune Checkpoint Inhibitor Therapy. Elsevier.
Warning: These citations may not always be 100% accurate.